Nuremberg, Germany

Markus Weniger

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Markus Weniger

Introduction

Markus Weniger is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of medical technology, particularly in the analysis of white blood cells. His innovative approach has the potential to enhance diagnostic methods in healthcare.

Latest Patents

Markus Weniger holds a patent for an in-vitro method for determining a cell type of a white blood cell without labeling. This method utilizes a microscopy apparatus to image the cell, allowing for the ascertainment of physical parameters through automated image analysis. The determination of the cell type is based on these physical parameters and principal component analysis parameters (PCA parameters), which consist of linear combinations of some of the physical parameters. This groundbreaking technique simplifies the process of identifying white blood cells, making it more efficient and effective.

Career Highlights

Weniger is currently employed at Siemens Healthineers AG, a leading company in the healthcare technology sector. His work focuses on advancing medical imaging and analysis techniques, contributing to improved patient outcomes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of innovation in his field.

Collaborations

Throughout his career, Markus Weniger has collaborated with talented professionals such as Lukas Richter and Oliver Hayden. These partnerships have fostered a creative environment that encourages the development of new ideas and technologies.

Conclusion

Markus Weniger's contributions to medical technology exemplify the impact of innovation in healthcare. His patented methods for analyzing white blood cells without labeling represent a significant advancement in diagnostic techniques. As he continues to work at Siemens Healthineers AG, his efforts will likely lead to further breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…